oxotremorine has been researched along with Esophageal Achalasia in 1 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Esophageal Achalasia: A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okasora, T | 1 |
| Okamoto, E | 1 |
| Toyosaka, A | 1 |
| Nakai, K | 1 |
| Niwamoto, H | 1 |
| Inoue, M | 1 |
1 other study available for oxotremorine and Esophageal Achalasia
| Article | Year |
|---|---|
[Comparative physiopathologic study on congenital Hirschsprung's disease and acquired esophageal achalasia].
Topics: Animals; Dose-Response Relationship, Drug; Esophageal Achalasia; Esophagus; Hirschsprung Disease; Hu | 1990 |